Recherche
Résultats 21-30 de 46
-
The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009 and 2019: a perspective from the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplantation, 30-03-2023, 1-4Article dans une revue scientifique -
Car t-cell therapy for the management of refractory/relapsed high-grade b-cell lymphoma: a practical overview
Bone Marrow Transplantation, 18-04-2020, 55, 1525–1532Article dans une revue scientifique -
Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey.
Bone Marrow Transplantation, 25-02-2022, 57, 742–752Article dans une revue scientifiquetexte intégral -
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMT.
Bone Marrow Transplantation, 26-06-2022, 57, 1421–1427Article dans une revue scientifique -
Measurable residual disease (MRD) status before allogeneic hematopoietic cell transplantation impact on secondary acute myeloid leukemia outcome. A Study from the Acute Leukemia Working Party (ALWP) of the European society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplantation, 18-07-2022, 57, 1556–1563Article dans une revue scientifique -
Autologous versus allogeneic hematopoietic cell transplantation for older patients with acute lymphoblastic leukemia. An analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Bone Marrow Transplantation, 09-01-2023Article dans une revue scientifique -
Allogeneic stem cell transplantation for patients with acute myeloid leukemia (AML) in second complete remission (CR2) transplanted from unrelated donors with post-transplant cyclophosphamide (PTCy). A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Bone Marrow Transplantation, 25-02-2023Article dans une revue scientifique -
Real-world use of defibrotide for veno-occlusive disease/sinusoidal obstruction syndrome: the DEFIFrance Registry Study.
Bone Marrow Transplantation, 25-12-2022Article dans une revue scientifiquetexte intégral -
Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMT.
Bone Marrow Transplantation, 04-12-2022, 58, 282–287Article dans une revue scientifique -
Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome unclassifiable - a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplantation, 21-11-2022, 58, 222–225Article dans une revue scientifique